What Is the Color for Parkinson’s Awareness?

Silver, sometimes described as gray, is the designated awareness color for Parkinson’s disease. You will see it most often in the form of a silver ribbon worn on lapels, printed on fundraising materials, or displayed on social media profile frames during April, which is recognized internationally as Parkinson’s Awareness Month. Alongside the ribbon, a red tulip serves as a second widely used symbol with its own distinct backstory. Both emblems aim to make a disease that affects millions of people more visible to the general public, and the reasons that visibility matters go well beyond symbolism.

Why Silver, and Where the Red Tulip Comes In

The choice of silver for Parkinson’s awareness does not have a single dramatic origin story the way pink does for breast cancer. It evolved through advocacy organizations in the 1990s and early 2000s as awareness ribbons became a standard shorthand for health causes. Silver was likely chosen because it was unclaimed by another major disease campaign and because its muted, metallic tone carried associations with aging and the brain. Some organizations use a slightly darker gray, but silver remains the most common shade on merchandise, event banners, and digital graphics from groups like the Parkinson’s Foundation and the Michael J. Fox Foundation.

The red tulip has a more specific origin. In the 1980s, a Dutch horticulturist named J.W.S. Van der Wereld, who had Parkinson’s disease himself, cultivated a new red-and-white tulip variety. He named it the “Dr. James Parkinson” tulip after the English physician who first described the condition in 1817. The European Parkinson’s Disease Association later adopted the red tulip as an international symbol. On World Parkinson’s Day, held every year on April 11 (James Parkinson’s birthday), you will see red tulip imagery across awareness campaigns worldwide. The two symbols serve slightly different audiences: the silver ribbon is more common in North American fundraising and walk events, while the red tulip has stronger roots in European advocacy circles. Both are correct and widely recognized.

What Most People Get Wrong About the Disease

Awareness campaigns exist because there is a real gap between what the public thinks Parkinson’s disease is and what people living with it actually experience. A scoping review of studies on public perceptions found that while many people had heard of Parkinson’s, their understanding was shallow. Most could name tremor as a symptom, but knowledge of non-motor symptoms and advanced treatments was poor.1PLOS ONE. Exploring public perceptions and awareness of Parkinson’s disease: A scoping review A cross-sectional survey in Portugal reinforced this pattern: motor symptoms like tremor and slow movement were widely recognized, but non-motor symptoms were largely unknown to the general population.2PubMed. Mapping public knowledge of Parkinson’s disease in Portugal: a cross-sectional survey of knowledge, perceptions and attitudes

That matters because Parkinson’s is not just a tremor disease. Non-motor symptoms can include depression, anxiety, sleep disturbances, loss of smell, constipation, cognitive changes, and fatigue. For many patients these problems show up years before the classic motor signs, and they can be just as disabling as difficulty walking. When the public thinks of Parkinson’s only as “the shaking disease,” it creates blind spots. Family members may not connect a loved one’s chronic constipation and sleep problems to a neurological condition. Even clinicians sometimes overlook early Parkinson’s in patients who do not yet have obvious tremor.

At a biological level, Parkinson’s involves the loss of dopamine-producing nerve cells in a part of the brain called the substantia nigra.3PubMed Central. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson’s disease A hallmark feature is the buildup of protein clumps known as Lewy bodies, which are largely made of a protein called alpha-synuclein.4PubMed. The Lewy body in Parkinson’s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates Because these changes affect brain regions beyond just the motor system, the wide range of symptoms makes more sense. Awareness campaigns that lean only on images of shaking hands inadvertently reinforce the misconception that tremor is the whole story.

Stigma and Why Symbols Matter in Practice

The silver ribbon and red tulip are not just decorative. Stigma is a documented problem for people with Parkinson’s, and visible symbols of solidarity can push back against it. A systematic review on stigma in the Parkinson’s community found that more than half of people with the disease conceal their diagnosis, mask their symptoms, or avoid going out in public because of how others react to them.5PubMed Central. Exploring the stigma experienced by people affected by Parkinson’s disease: a systematic review Tremor, slowness, and reduced facial expression are often misread by strangers. A person whose face does not move much during conversation can be perceived as unfriendly, disinterested, or cognitively impaired when in reality they are fully engaged but their facial muscles are not cooperating.

Lack of public understanding is a major driver of that stigma. When people around you do not know what Parkinson’s looks like beyond a vague sense of “old person shaking,” any visible symptom that deviates from that template becomes confusing or uncomfortable. Wearing a silver ribbon or displaying a red tulip creates an opening for conversation. Awareness events like community walks, fundraising galas, and social media campaigns during April give people with Parkinson’s a context in which their condition is acknowledged and normalized rather than hidden. For caregivers, these symbols also serve as a quick signal that can reduce the amount of explaining they have to do in public spaces.

The Diagnostic Challenge for Younger People

One area where better public awareness could make a tangible difference is in how quickly younger people get diagnosed. Parkinson’s is strongly associated with older adults, and for good reason: the average age at diagnosis is around 60. But roughly 5 to 10 percent of cases are classified as young-onset, meaning they begin before age 50, and some people develop symptoms in their 30s or even 20s.

A study comparing diagnostic timelines found that younger patients took an average of 15 additional months longer to receive a Parkinson’s diagnosis than older patients did.6PubMed. Challenges in diagnosis of young onset Parkinson’s disease Younger patients also required significantly more neurologist visits and clinical investigations before someone landed on the right answer. The researchers suggested that the delay was not because younger patients had more ambiguous symptoms; it was because Parkinson’s simply was not considered as a possibility for an extended period, given the patient’s age. When a 35-year-old walks into a clinic with a stiff arm and trouble sleeping, the mental shortcut “too young for Parkinson’s” can send both patient and doctor down a long list of wrong leads.

Qualitative research on this diagnostic journey paints an even starker picture. A study exploring the social processes around early-onset diagnosis found that the process typically stretched over two years and frequently involved misdiagnosis. Doctors tended to attribute symptoms to psychological causes, especially stress and anxiety, partly because of assumptions tied to the patient’s age. Receiving the correct diagnosis was described by participants as a kind of redemption after years of being told the problem was in their head.7PubMed. Constructing the detecting stage: Social processes and the diagnostic journey of early onset Parkinson’s disease This is exactly the kind of problem that broader awareness can chip away at. If the general public and primary care clinicians both understood that Parkinson’s is not exclusively a disease of the elderly, fewer young patients would spend years searching for answers.

A Fast-Growing Global Health Concern

The urgency behind Parkinson’s awareness campaigns is growing alongside the disease itself. Global incidence and prevalence have been climbing steadily. An analysis of data from 1990 to 2021 found that age-standardized rates of Parkinson’s incidence, prevalence, disability, and mortality all increased over that period, with men affected more than women across every measure.8PubMed Central. Global burden of Parkinson’s disease from 1990 to 2021: a population-based study

The projections looking forward are striking. A modeling study based on the Global Burden of Disease dataset estimated that the number of people living with Parkinson’s worldwide will reach roughly 25 million by 2050, more than doubling from 2021 levels. The study projected about 15.6 million cases by 2030 and 20.4 million by 2040.9BMJ. Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021 An aging global population is the biggest factor behind these numbers, but the increase is not explained by aging alone, which is part of why researchers and advocates are pushing for more attention and funding now rather than later.

Those numbers translate into enormous costs for healthcare systems and families. Parkinson’s requires long-term management that escalates over time, from medication to physical therapy to, in some cases, surgical interventions like deep brain stimulation. Caregiver burden is substantial, and many people with Parkinson’s eventually need assistance with daily activities. The silver ribbon on someone’s jacket during April is, in a very real sense, a signal that the scale of this problem is large and getting larger.

New Diagnostic Tools and Research Momentum

Awareness campaigns do not just change how people think about Parkinson’s. They also channel money and political will toward research, and the research landscape has shifted meaningfully in recent years. Disease-focused nonprofit organizations play a direct role in speeding new treatments through both funding and advocacy.10PubMed Central. A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders Groups like the Michael J. Fox Foundation have invested hundreds of millions of dollars in Parkinson’s research since their founding, funding everything from basic science to clinical trials. Much of that money is raised through events and campaigns built around the silver ribbon and April awareness month.

One concrete example of recent progress involves a diagnostic test called the alpha-synuclein seed amplification assay. Because Parkinson’s diagnosis has traditionally relied on clinical observation of motor symptoms, which appear only after significant brain damage has already occurred, there has been a long push to develop a biological test that can detect the disease earlier and more precisely. A study evaluating this assay found it correctly identified all Parkinson’s samples as positive, with the ability to distinguish Parkinson’s from other neurodegenerative conditions that can look similar clinically.11PubMed. α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders While still being refined for widespread clinical use, this kind of test represents a potential shift from diagnosing Parkinson’s based on visible symptoms to detecting the underlying biology of the disease. That shift could eventually allow treatment to begin earlier, when interventions might have a bigger impact on slowing progression.

How to Participate in Parkinson’s Awareness

If you want to show support during April or at any point during the year, the options go well beyond buying a ribbon. Wearing silver is the most visible gesture, and it does serve a purpose in sparking conversations, but there are more substantive ways to engage. Local Parkinson’s organizations host walks, runs, and cycling events that raise money directly for research and patient support services. Many of these events welcome participants who are not personally affected by the disease.

Educating yourself about the non-motor side of Parkinson’s is itself a form of awareness. When you understand that a neighbor’s reduced facial expression or quiet voice might be Parkinson’s rather than rudeness, you change the social environment for that person in a small but meaningful way. If you are in a workplace, advocating for accommodations for employees with Parkinson’s, such as flexible scheduling for medication timing or reduced expectations around physical tasks that require fine motor control, translates awareness into something material. Parkinson’s is a condition where being seen and understood by the people around you can meaningfully affect quality of life, and that begins with knowing what the silver ribbon stands for and why it exists.

Other Colors and Symbols in the Parkinson’s Orbit

You may occasionally see Parkinson’s grouped with other neurological or brain-related causes under a gray or silver umbrella, since gray and silver are used for brain cancer awareness and some broader “brain health” campaigns as well. This can cause confusion. If you see a gray ribbon without context, it could represent Parkinson’s, brain tumors, asthma, or diabetes, depending on the shade and the organization using it. The red tulip, by contrast, is unique to Parkinson’s and is the least ambiguous symbol if you want to be specifically clear about what you are supporting.

Some Parkinson’s organizations have experimented with adding blue to their branding, and you will see teal or blue-gray combinations on certain campaign materials. These are organizational choices rather than universal standards. The Parkinson’s Foundation uses red as a primary brand color on its website and materials, which can add to the confusion. If you are purchasing awareness merchandise or making a donation, the safest bet is to look for the silver ribbon or the red tulip specifically labeled for Parkinson’s disease rather than relying on color alone. The disease awareness color system in general is crowded and inconsistent, with multiple conditions sharing the same ribbon shade, which is one reason the Parkinson’s community has leaned into the tulip as a more distinctive marker.